Importantly, NVB selectively kills cancer cells harboring HR deficiency (BRCA1- and BRCA2-deficiency) and potentiates the cytotoxic effect of PARP inhibition in HR-deficient cancer cells [145]. Here, BRCA1 is linked to cancer.